SMT201900288T1 - Acidi ialuronici solfatati come agenti antivirali - Google Patents

Acidi ialuronici solfatati come agenti antivirali

Info

Publication number: SMT201900288T1
Authority: SM; San Marino
Prior art keywords: antiviral agents; hyaluronic acids; sulphated hyaluronic; sulphated; acids
Prior art date: 2009-05-14

Application number

SM20190288T

Other languages

English (en)

Inventor

Devis Galesso

Anna Maria Zanellato

Original Assignee

Fidia Farm Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-14

Filing date

2010-05-11

Publication date

2019-07-11

2010-05-11 Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa

2019-07-11 Publication of SMT201900288T1 publication Critical patent/SMT201900288T1/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
AIDS & HIV (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Obesity (AREA)

SM20190288T 2009-05-14 2010-05-11 Acidi ialuronici solfatati come agenti antivirali SMT201900288T1 (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ITPD2009A000135A IT1397247B1 (it)	2009-05-14	2009-05-14	Nuovi agenti regolatori dell'attivita' citochinica
EP16178622.3A EP3103459B1 (en)	2009-05-14	2010-05-11	Sulphated hyaluronic acids as antiviral agents

Publications (1)

Publication Number	Publication Date
SMT201900288T1 true SMT201900288T1 (it)	2019-07-11

Family

ID=41268269

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SM20190288T SMT201900288T1 (it)	2009-05-14	2010-05-11	Acidi ialuronici solfatati come agenti antivirali
SM201600456T SMT201600456B (it)	2009-05-14	2016-12-14	Acidi ialuronici solfatati come agenti regolatori dell'attività citochinica

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SM201600456T SMT201600456B (it)	2009-05-14	2016-12-14	Acidi ialuronici solfatati come agenti regolatori dell'attività citochinica

Country Status (15)

Country	Link
US (2)	US9808482B2 (it)
EP (2)	EP2429533B1 (it)
CN (2)	CN108379288B (it)
CA (2)	CA2761627C (it)
ES (2)	ES2722436T3 (it)
HR (1)	HRP20161575T8 (it)
HU (1)	HUE031174T2 (it)
IT (1)	IT1397247B1 (it)
LT (1)	LT2429533T (it)
PL (1)	PL2429533T3 (it)
PT (1)	PT2429533T (it)
RU (1)	RU2552337C2 (it)
SI (1)	SI2429533T1 (it)
SM (2)	SMT201900288T1 (it)
WO (1)	WO2010130466A1 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8343942B2 (en) *	2008-04-04	2013-01-01	University Of Utah Research Foundation	Methods for treating interstitial cystitis
EP2281008B1 (en)	2008-04-04	2017-01-04	University of Utah Research Foundation	Alkylated and sulfated hyaluronan compounds, methods for their preparation and use thereof
IT1397246B1 (it) *	2009-05-14	2013-01-04	Fidia Farmaceutici	Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
US20130209531A1 (en)	2010-06-08	2013-08-15	University Of Utah Research Foundation	Applications of partially and fully sulfated hyaluronan
AU2012230822A1 (en)	2011-03-23	2013-11-07	University Of Utah Research Foundation	Methods for treating or preventing urological inflammation
GB201219696D0 (en)	2012-11-01	2012-12-12	Univ Liverpool	Agents for the prevention and/or treatment of central nervous system damamge
WO2018053111A1 (en)	2016-09-15	2018-03-22	University Of Utah Research Foundation	In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
CN111228653A (zh)	2018-11-13	2020-06-05	格莱科米拉治疗公司	用电离辐射加强癌症治疗的方法
CN109529021B (zh) *	2019-01-25	2022-11-15	山东省分析测试中心	一种白细胞介素2抑制破骨细胞生成和功能的新用途
IT201900003887A1 (it)	2019-03-18	2020-09-18	Fidia Farm Spa	Sistemi di stabilizzazione e di rilascio controllato di farmaci instabili alla sterilizzazione
WO2021133000A1 (ko) *	2019-12-23	2021-07-01	주식회사 엘지화학	항염 또는 항혈관신생용 약제학적 조성물
EP4117683A4 (en)	2020-03-12	2024-04-24	Sydney David Cullis-Hill	Treatment for coronavirus infection and associated cytokine toxicity
IT202000032243A1 (it)	2020-12-23	2022-06-23	Fidia Farm Spa	Nuovi agenti antivirali

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0240098A3 (en) *	1986-04-04	1989-05-10	Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo	Oligo and polysaccharides for the treatment of diseases caused by retroviruses
IT1217458B (it) *	1988-05-02	1990-03-22	Crinos Ind Farmacoriologica S	Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease
DE4021066A1 (de) *	1990-07-03	1992-01-09	Hoechst Ag	Langzeitprophylaxe gegen erkrankungen, die durch viren oder durch unkonventionelle viren verursacht werden
ITPD940054A1 (it) *	1994-03-23	1995-09-23	Fidia Advanced Biopolymers Srl	Polisaccaridi solfatati
WO1996024362A1 (en) *	1995-02-07	1996-08-15	Shiseido Company, Ltd.	Antiinflammatory agents
JPH10195107A (ja) *	1997-01-10	1998-07-28	Shiseido Co Ltd	オリゴ硫酸化ヒアルロン酸
AU738788B2 (en) *	1997-04-04	2001-09-27	Fidia Farmaceutici S.P.A.	N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
US5981509A (en) *	1997-05-20	1999-11-09	Shiseido Company, Ltd.	Preparation for prophylaxis or treatment of renal diseases containing sulfated polysaccharide
JPH11147901A (ja) *	1997-11-19	1999-06-02	Maruho Co Ltd	カリクレイン−キニン系阻害剤
JPH11269077A (ja) *	1998-03-19	1999-10-05	Maruho Co Ltd	ホスホリパーゼａ２阻害用医薬組成物
DE19813234A1 (de) *	1998-03-26	1999-09-30	Knoell Hans Forschung Ev	Verfahren zur Herstellung hochsulfatierter Hyaluronsäuren
JP2000178196A (ja) *	1998-12-11	2000-06-27	Seikagaku Kogyo Co Ltd	新規ヒアルロニダーゼ阻害剤及び外用剤
JP2001163789A (ja) *	1999-12-13	2001-06-19	Maruho Co Ltd	マトリックスメタロプロテアーゼ阻害用医薬組成物
GB0003048D0 (en) *	2000-02-11	2000-03-29	Dealler Stephen F	The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism
US7431920B2 (en) *	2000-07-19	2008-10-07	Pepgen Corporation	Method of treating IL-10 deficiency
DE10053053A1 (de)	2000-10-19	2002-05-16	Knoell Hans Forschung Ev	Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
US20030162732A1 (en) *	2001-07-05	2003-08-28	Astion Development A/S	Combination of aminosugars and cysteine or cysteine derivatives
ITPD20020271A1 (it) *	2002-10-18	2004-04-19	Fidia Farmaceutici	Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
DE10349722A1 (de) *	2003-10-23	2005-06-16	Beschorner, Katharina, Dr.	Zusammensetzung zur Arthrose-/Arthritisbehandlung, insbesondere von Gelenken
DE10352137A1 (de) *	2003-11-04	2005-06-16	Beschorner, Katharina, Dr.	Verwendung sulfatierter Hyaluronsäure
ITPD20040245A1 (it) *	2004-10-08	2005-01-08	Fidia Advanced Biopolymers Srl	Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali
DE102005004643B4 (de) *	2005-01-28	2010-04-08	Innovent E.V. Technologieentwicklung	Antivirale Kombinationen sowie ihre Verwendung
ITPD20050168A1 (it) *	2005-06-01	2006-12-02	Fidia Advanced Biopolymers Srl	Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
US7517856B2 (en) *	2005-10-11	2009-04-14	Ben-Gurion University Of The Negev Research And Development Authority	Bioconjugates comprising sulfated polysaccharides and their uses
JP4220513B2 (ja) *	2005-12-01	2009-02-04	株式会社資生堂	カチオン化ヒアルロン酸
ITPD20060219A1 (it) *	2006-05-31	2007-12-01	Fidia Farmaceutici	Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
EP2025687A1 (en) *	2007-07-23	2009-02-18	Istituto Scientifico di Chimica E Biochimica "G Ronzoni	Process for the preparation of heparanase-inhibiting sulfated hyaluronates and products obtained thereby
EP2090308A1 (en) *	2008-02-15	2009-08-19	Bone Therapeutics	Pharmaceutical composition for the treatment or prevention of osteoarticular diseases
IT1397246B1 (it) *	2009-05-14	2013-01-04	Fidia Farmaceutici	Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica

2009
- 2009-05-14 IT ITPD2009A000135A patent/IT1397247B1/it active
2010
- 2010-05-11 SM SM20190288T patent/SMT201900288T1/it unknown
- 2010-05-11 LT LTEP10721125.2T patent/LT2429533T/lt unknown
- 2010-05-11 HU HUE10721125A patent/HUE031174T2/en unknown
- 2010-05-11 CN CN201810521049.XA patent/CN108379288B/zh active Active
- 2010-05-11 WO PCT/EP2010/003044 patent/WO2010130466A1/en not_active Ceased
- 2010-05-11 EP EP10721125.2A patent/EP2429533B1/en active Active
- 2010-05-11 SI SI201031341A patent/SI2429533T1/sl unknown
- 2010-05-11 US US13/320,015 patent/US9808482B2/en active Active
- 2010-05-11 RU RU2011146049/15A patent/RU2552337C2/ru active IP Right Revival
- 2010-05-11 ES ES16178622T patent/ES2722436T3/es active Active
- 2010-05-11 ES ES10721125.2T patent/ES2602498T3/es active Active
- 2010-05-11 CA CA2761627A patent/CA2761627C/en active Active
- 2010-05-11 PT PT107211252T patent/PT2429533T/pt unknown
- 2010-05-11 HR HRP20161575TT patent/HRP20161575T8/hr unknown
- 2010-05-11 EP EP16178622.3A patent/EP3103459B1/en active Active
- 2010-05-11 CA CA2967567A patent/CA2967567C/en active Active
- 2010-05-11 CN CN201080020643.2A patent/CN102421443B/zh active Active
- 2010-05-11 PL PL10721125T patent/PL2429533T3/pl unknown
2016
- 2016-12-14 SM SM201600456T patent/SMT201600456B/it unknown
2017
- 2017-09-20 US US15/710,275 patent/US10548918B2/en active Active

Also Published As

Publication number	Publication date
HUE031174T2 (en)	2017-06-28
CN102421443B (zh)	2018-06-26
PL2429533T3 (pl)	2017-02-28
CN102421443A (zh)	2012-04-18
ITPD20090135A1 (it)	2010-11-15
CA2967567C (en)	2018-09-11
US10548918B2 (en)	2020-02-04
EP3103459A2 (en)	2016-12-14
ES2602498T3 (es)	2017-02-21
SMT201600456B (it)	2017-01-10
SI2429533T1 (sl)	2017-01-31
HK1258973A1 (zh)	2019-11-22
US9808482B2 (en)	2017-11-07
US20120101059A1 (en)	2012-04-26
CA2761627A1 (en)	2010-11-18
EP2429533A1 (en)	2012-03-21
LT2429533T (lt)	2016-12-12
PT2429533T (pt)	2016-11-14
CN108379288B (zh)	2020-10-16
RU2552337C2 (ru)	2015-06-10
RU2011146049A (ru)	2013-06-20
IT1397247B1 (it)	2013-01-04
ES2722436T3 (es)	2019-08-12
CA2967567A1 (en)	2010-11-18
HRP20161575T1 (hr)	2016-12-30
HRP20161575T8 (hr)	2019-01-25
EP3103459A3 (en)	2017-01-18
US20180008628A1 (en)	2018-01-11
WO2010130466A1 (en)	2010-11-18
EP2429533B1 (en)	2016-09-07
EP3103459B1 (en)	2019-02-27
CN108379288A (zh)	2018-08-10
CA2761627C (en)	2017-07-04

Publication	Publication Date	Title
SMT201900288T1 (it)	2019-07-11	Acidi ialuronici solfatati come agenti antivirali
GB0900914D0 (en)	2009-03-04	Antiviral agents
HRP20171759T8 (hr)	2021-05-14	Antiviralni spojevi
PL2403852T3 (pl)	2015-04-30	2-aminobenzoimidazolo-5-karboksyamidy jako środki przeciwzapalne
IL233822A0 (en)	2014-09-30	New anti-inflammatory agents
PL2411246T3 (pl)	2016-06-30	Konstrukcja zderzaka
IL215194A0 (en)	2011-12-29	Novel anti-inflammatory agents
IL219965A0 (en)	2012-07-31	Novel antiviral compounds
GB0815968D0 (en)	2008-10-08	Antiviral agents
PL2637710T3 (pl)	2017-10-31	Preparaty na bazie kwasu hialuronowego
PL2519250T3 (pl)	2016-12-30	Analogi interferonu
EP2431234A4 (en)	2012-10-17	BUMPER STRUCTURE
EP2518051A4 (en)	2013-10-16	ADAMANTANAMINE DERIVATIVE
IL216026A0 (en)	2012-01-31	Heterocyckic antiviral compounds
IL218500A0 (en)	2012-07-31	Apogossypolone derivatives as anticaner agents
GB0905485D0 (en)	2009-05-13	Antiviral therapy
GB0917994D0 (en)	2009-12-02	Light bus
GB0910983D0 (en)	2009-08-05	Washing line assistant
AU2009906172A0 (en)	2010-01-07	Antiviral agents
GB0811637D0 (en)	2008-07-30	Hyaluronic acid crtogel
GB0911022D0 (en)	2009-08-12	Novel purines
TWM390785U (en)	2010-10-21	Sputum-patting assistant structure
ZA201203613B (en)	2013-08-28	Novel antiviral compounds
GB0922520D0 (en)	2010-02-10	Novel antiviral compounds
GB0909171D0 (en)	2009-07-08	Versatile aircraft